US Amgen ruling keeps generic psoriasis drug off market until 2028, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The U.S. Court of Appeals for the Federal Circuit affirmed a New Jersey federal court’s ruling that Amgen patents covering the drug were valid and that the proposed generics would infringe them., The U.S. Court of Appeals for the Federal Circuit affirmed a New Jersey federal court’s ruling that Amgen patents covering the drug were valid and that the proposed generics would infringe them., , Read More

Leave a Reply

Your email address will not be published.